Contents:
From: Acta Clinica Belgica Vol. Publisher: Acta Clinica Belgica. Document Type: Book review.
Length: words. Masur, F. Furthermore the Metabolic Syndrome, which is characterized by obesity, insulin resistance, hypertension, dyslipidemia and elevated risk of diabetes, polycystic ovary syndrome, stroke and Alzheimer's disease, is associated with a higher incidence of more aggressive triple negative breast tumors.
The increased risk is accelerated by the decline in ovarian estrogen levels after menopause, as pre-menopausal women are protected from the deleterious metabolic effects of obesity, including chronic tissue inflammation and insulin- resistance. Studies in rodents have confirmed this relationship, showing that dietary-induced obesity and high fat diets lead to increased incidence and growth of tumors in oncogene and carcinogen-induced breast cancers.
Despite this body of correlative evidence, the mechanisms of obesity-induced breast cancer risk remain poorly understood. Dietary composition is an important factor as diets rich in saturated and omega 6 fatty acids are pro-inflammatory and increase breast cancer risk, but diets rich in omega 3 fatty acids are anti-inflammatory and decrease cancer risk.
This book, at the forefront of experimental and clinical research, is the first to highlight the common molecular links between these two diseases. These tight links indicate a complex interdependency between both diseases on a cellular and hormonal basis, which is influenced by a variety of aspects e. Special attention has been given to the fundamental role of the switch from oxidative phosphorylation to glycolysis of cancer cells - the Warburg effect.
J Hepatol. Other ADTs Acarbose or miglitol , which interfere with glucose absorption, correlated with increased kidney and decreased lung, gastric and hepatic cancers in preliminary studies that included small numbers of patients and need confirmation including correction for confounding factors related to hyperglycaemia HbA1c Lutz et al , Cancer mortality among diabetics. In the late 20 th century, with great advancement of biomedical sciences, a number of molecular signatures or biomarkers were identified as predictors of disease initiation, progression, and response to treatment, including diabetes and tumors. Given this, there has been a thrust to look more widely than traditional lifestyle and biomedical risk factors.